3-n-(2-fluoroethyl)spiperone has been researched along with Schizophrenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bravi, D; Cavallaro, R; Colombo, C; Fazio, F; Galli, L; Gobbo, C; Lucignani, G; Messa, C; Moresco, RM; Rizzo, G; Smeraldi, E; VelonĂ , I | 1 |
Coenen, HH; Heiss, WD; Jovkar, S; Laufer, P; Pawlik, G; Rudolf, J; Stöcklin, G; Wienhard, K | 1 |
1 trial(s) available for 3-n-(2-fluoroethyl)spiperone and Schizophrenia
Article | Year |
---|---|
Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Double-Blind Method; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Prospective Studies; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Spiperone | 2004 |
1 other study(ies) available for 3-n-(2-fluoroethyl)spiperone and Schizophrenia
Article | Year |
---|---|
PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system.
Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Female; Humans; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Spiperone; Tomography, Emission-Computed | 1990 |